Consistent with its function in other cancers, CASC2 knockdown significantly promoted tumor cell viability, suppressed tumor cell apoptosis, and increased the resistance of hepatocellular carcinoma cell to TRAIL. This evidence concerns the gene CASC2 and hepatocellular carcinoma.